Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol

Journal List Int J Womens Dermatol v.5(1); 2019 Feb PMC6374694 As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright Notice Int J Womens Dermatol. 2019 Feb; 5(1): 46–51. Published online 2018 Sep 21. doi:10.1016/j.ijwd.2018.08.004PMCID: PMC6374694PMID: 30809579J. Stevens, BSa,⁎ and S. Khetarpal, MDbAuthor information Article notes Copyright and License information PMC DisclaimerAbstractAndrogenetic alopecia (AGA) is a common hair loss disorder caused by genetic and hormonal factors that are characterized by androgen-related progressive thinning of scalp hair in a defined pattern. By the age of 60 years, 45% of men and 35% of women develop AGA. Currently, U.S. Food and Drug Administration-approved treatments for AGA include oral finasteride and topical minoxidil. Due to the limited number of effective th...